Gland Pharma, Neuland Laboratories team up for sterile API manufacturing

Gland Pharma and Neuland Laboratories have entered into a long-term CDMO partnership to manufacture sterile APIs for microparticle depot products. Gland Pharma will establish a dedicated sterile manufacturing suite at its Visakhapatnam facility, built to cGMP, USFDA and EU standards. The facility will add around 1,400 kg of annual capacity and provide integrated development, scale-up, regulatory support and commercial manufacturing capabilities for complex sterile APIs.
Evaluating a similar location, plant, or policy window?
Bucephalus advises on greenfield industrial projects in South India.
Talk to Bucephalus